Foghorn Therapeutics' Seed VC Round

Foghorn Therapeutics raised a round of funding on March 14, 2018. Investors include Flagship Pioneering.

Foghorn Therapeutics is developing therapies based on a system that directs which genes cells express, and when, where, and in what order. By manipulating this system with its unique Gene Traffic Cont…

Articles about Foghorn Therapeutics' Seed VC Round: